Global Antibiotic Research and Development Partnership (Gardp)

GARDP is a not-for-profit focused on developing treatments for drug-resistant infections.

🤖

AI Overview

With $60K in lobbying spend across 4 quarterly filings, Global Antibiotic Research and Development Partnership (Gardp) is an active lobbying client. Their lobbying covers 2 issue areas.

$60K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2021	$60K

Issues Lobbied

MED Budget/Appropriations

Lobbying Firms

Faegre Drinker Biddle & Reath LLP

Lobbyists

Jodie Curtis Laura Hanen

Government Agencies Targeted

These are the government entities that Global Antibiotic Research and Development Partnership (Gardp) disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED, Budget/Appropriations

Drug resistance and antibiotic development.

FY22 appropriations regarding antibiotic research and development.

Antimicrobial resistance; antibiotic research and development.

FY 2022 appropriations regarding antibiotic research and development.

Antimicrobial resistance; Antibiotic research and development; Pandemic preparedness as it relates to antimicrobial resistance; S. 2076, H.R. 3932 - PASTEUR Act; H.R. 2036 - Saving Us from Pandemic Er